Skip to main content

Proteomics: State of the Art and its Application in Cardiovascular Research

Buy Article:

$63.00 plus tax (Refund Policy)

Abstract:

The cellular and molecular mechanisms underlying cardiovascular dysfunctions are widely unknown. Basically, pathological changes in the cardiovascular system arise from protein alterations. Proteomics comprises a set of tools for the large-scale study of gene expression at the protein level thereby allowing for the identification of protein alterations responsible for the development and the pathological outcome of diseases including those of the cardiovascular system. In principle these alterations include those of suitable candidates for drug targets and disease biomarkers as well as therapeutic proteins / peptides. Since gene therapy depends on the function of a therapeutic protein encoded by a “therapeutic” gene proteomic analyses also provide the basis for the design and application of gene therapies.

Proteomic technologies allow to identify not only proteins but also the nature of their posttranslational modifications thus enabling the elucidation of signal transduction pathways and their deregulation under pathological conditions. The linkage of information about proteome changes with functional consequences lead to the development of functional proteomic studies. Functional proteomic analyses will particularly help to better understand the relations between proteome changes and cardiovascular dysfunctions.

The storage and administration of experimental data obtained by the application of proteomic analyses is supported by species- and tissue-specific protein databases and specific software. Publications in this field are reviewed in this paper.

Keywords: cardiovascular disease; mass spectrometry; polyacrylamide gel electrophoresis; posttranslational modification; protein identification; protein-protein interaction; proteomic analysis

Document Type: Review Article

DOI: http://dx.doi.org/10.2174/0929867043363767

Affiliations: Department of Cardiology and Angiology, Universitatsklinikum, Albert-Schweitzer-Str. 33, D-48129 Munster, Germany.

Publication date: December 1, 2004

More about this publication?
  • Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
ben/cmc/2004/00000011/00000024/art00004
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more